Zambon Acquires Breath Therapeutics for Up-to-€500M, Adding to Respiratory Pipeline - Genetic Engineering & Biotechnology News

Zambon Acquires Breath Therapeutics for Up-to-€500M, Adding to Respiratory Pipeline  Genetic Engineering & Biotechnology News

Italian pharma Zambon said today it has acquired Breath Therapeutics and its subsidiaries for up to €500 million (about $559 million), in a deal that adds a ...



Comments

Popular posts from this blog

Rashes that look like scabies: Causes, symptoms, and treatment - Medical News Today

Urinary Tract Infection (UTI): Causes, Symptoms & Treatment - Cleveland Clinic

Symtuza: Uses, side effects, alternatives, and more - Medical News Today